PacBio (PACB) Reports Impressive Preliminary Q4, FY21 Revenues

Jan 17, 2022 · PacBio's (PACB) solid fourth-quarter results are likely to have been boosted by strong segmental performances and robust placement of Sequel systems.

33%
OFF

PacBio Announces Record Preliminary Fourth Quarter 2021 …

2 weeks from now

Jan 11, 2022 · Expect preliminary fourth quarter revenue of approximately $36.0 million, representing an increase of approximately 33% compared with $27.1 million for the fourth …

pacb.com

33%
OFF

PacBio (PACB) Reports Impressive Preliminary Q4, FY21 Revenues

2 weeks from now

As per the preliminary report, fourth-quarter revenues are likely to be about $36 million, reflecting a year-over-year improvement of 33%. The Zacks Consensus Estimate of $35.9 million remains below the preliminary figure. During the fourth quarter, PacBio confirmed placing a record 48 Sequel II/IIe systems, up 37.1% from the year-ago period. Preli...

nasdaq.com

$16
OFF

PacBio Announces Record Preliminary Fourth Quarter 2021 …

2 weeks from now

Jan 11, 2022 · Preliminary instrument revenue for the fourth quarter of 2021 is expected to be approximately $16.2 million, compared with $15.9 million for the third quarter of 2021, and …

yahoo.com

113%
OFF

PacBio (PACB) Preliminary Q4 Revenues Boosted By Revio Sales

2 weeks from now

Jan 9, 2024 · Per the preliminary report, fourth-quarter 2023 total revenues are estimated to be $58.4 million, up 113% year over year. The Zacks Consensus Estimate of $54.1 million lies …

yahoo.com

$8.84
OFF

PacBio Prel. Q4 Revenue Surges, But Stock Down In Pre-market

2 weeks from now

Jan 8, 2024 · The fourth quarter results are expected to be reported in February along with the guidance for fiscal 2024. In pre-market activity, PacBio shares are trading at $8.84, down …

businessinsider.com

33%
OFF

PacBio Preliminary Q4 Revenue Up Approx. 33% - Quick Facts

2 weeks from now

Jan 11, 2022 · (RTTNews) - PacBio (PACB) reported preliminary revenue of approximately $36.0 million for its fourth quarter ended December 31, 2021, an increase of approximately 33% …

nasdaq.com

$58
OFF

PacBio Announces Record Preliminary Fourth Quarter And Full Year ...

2 weeks from now

Jan 8, 2024 · PacBio (PACB) achieved record revenue in 2023, with $58.4 million in Q4 and $200.5 million for the full year. ... Investors should note the preliminary Q4 instrument revenue …

stocktitan.net

$17
OFF

PacBio Announces Fourth Quarter And Fiscal Year 2021 …

2 weeks from now

Operating expenses for the fourth quarter of 2021 and the fourth quarter of 2020 included non-cash stock-based compensation of $17.5 million and $4.8 million, respectively. Net loss for the …

pacificbiosciences.com

$15
OFF

PacBio Announces Preliminary Fourth Quarter And Full Year Revenue

2 weeks from now

1 day ago · Preliminary instrument revenue for the fourth quarter of 2024 is expected to be approximately $15.3 million, compared with $35.1 million for the fourth quarter of 2023. …

yahoo.com

$39
OFF

PacBio Announces Preliminary Q4 Revenue Of $39.2M

2 weeks from now

1 day ago · PacBio (NASDAQ:PACB) on Tuesday announced preliminary unaudited revenue for the fourth quarter of 2024 and full year 2024 of $39.2 million and $154 million, representing a …

seekingalpha.com

$39
OFF

PacBio Announces Preliminary Q4 Revenue Of $39.2M - MSN

2 weeks from now

PacBio (NASDAQ:PACB) on Tuesday announced preliminary unaudited revenue for the fourth quarter of 2024 and full year 2024 of $39.2 million and $154 million, representing a year-over …

msn.com

$36
OFF

PacBio Announces Fourth Quarter And Fiscal Year 2021 Financial …

2 weeks from now

Feb 27, 2022 · PacBio (NASDAQ: PACB) today announced financial results for the quarter and fiscal year ended December 31, 2021. ... Achieved record fourth quarter revenues of $36.0 …

pacb.com

$39
OFF

PacBio Expects Q4, FY24 Revenues To Decline - Markets Insider

2 weeks from now

19 hours ago · (RTTNews) - PacBio (PACB), Tuesday announced preliminary revenue for the fourth quarter of 2024 and full year 2024 of $39.2 million and $154.0 million representing a …

businessinsider.com

$15
OFF

PacBio Announces Preliminary Fourth Quarter And Full Year

2 weeks from now

1 day ago · Preliminary instrument revenue for the fourth quarter of 2024 is expected to be approximately $15.3 million, compared with $35.1 million for the fourth quarter of 2023. …

globenewswire.com

FAQs about PacBio (PACB) Reports Impressive Preliminary Q4, FY21 Revenues Coupon?

How much revenue will PacBio generate in Q4 2021?

PacBio expects to generate approximately $4.8 million in service and other revenue for the fourth quarter of 2021, which is an increase from the $4.4 million in the third quarter of 2021 and the $3.5 million in the fourth quarter of 2020. ‘2021 was a transformational year for PacBio. ...

What was PacBio's fourth quarter revenue?

PacBio reported preliminary, unaudited revenue of approximately $58.4 million for its fourth quarter ended December 31, 2023. Preliminary instrument revenue for the fourth quarter of 2023 is expected to be approximately $35.1 million, compared with $6.1 million for the fourth quarter of 2022. ...

How much did PacBio (PACB) earn in Q4 2024?

(RTTNews) - PacBio (PACB), Tuesday announced preliminary revenue for the fourth quarter of 2024 and full year 2024 of $39.2 million and $154.0 million representing a year-over-year decline of 33% and 23%, respectively. ...

How much revenue did PacBio generate from revio?

Per management, approximately 67% of consumable revenues were generated from Revio in the fourth quarter for an annualized pull-through of approximately $385 thousand. PacBio shipped 44 Revio sequencing systems for revenues during fourth-quarter 2023, thereby bringing the Revio installed base to 173 systems as of Dec 31, 2023. ...

Is PacBio stock down in pre-market?

PacBio Prel. Q4 Revenue Surges, But Stock Down In Pre-market (RTTNews) - Pacific Biosciences of California, Inc. (PACB) Monday said that its preliminary revenue for the fourth quarter and the full year increased by 113 percent and 56 percent respectively, year on year. ...

When will PacBio's fourth quarter results be reported?

The fourth quarter results are expected to be reported in February along with the guidance for fiscal 2024. In pre-market activity, PacBio shares are trading at $8.84, down 5.96% on the Nasdaq. ...